NewGenIvf Group Limited Announces Pricing of $2.5 Million Underwritten Offering
Key Highlights
- ➤NewGenIvf (NIVF) prices $2.5 million underwritten offering
- ➤Offering includes 71,428,570 Class A Ordinary Shares or pre-funded warrants
- ➤Offering price is $0.035 per share or $0.03499 per pre-funded warrant
- ➤Net proceeds targeted for general corporate purposes and working capital
- ➤Transaction expected to close on or about November 20, 2026
BANGKOK, Nov. 19, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a technology-driven, diversified growth company, today announced the pricing of a firm commitment underwritten offering with gross proceeds to the Company expected to be approximately $2.5 million, before deducting underwriting fees and other offering expenses payable by the Company.
The offering consists of 71,428,570 Class A Ordinary Shares (or Pre-Funded Warrants in lieu thereof). The offering price per Class A Ordinary Share is $0.035 (or $0.03499 for each Pre-Funded Warrant, which is equal to the offering price per Class A Ordinary Share to be sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant). The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Warrant sold in the offering, the number of Class A Ordinary Shares in the offering will be decreased on a one-for-one basis.
Get started
Create a free account to read the full story.
